In this study we describe likely pathogenic or rare missense variants in the BMPR2 pathway gene SMAD6 in 4 of 32 (12.5%) patients with CHD-APAH and in 2 out of 311 (0.64%) patients with IPAH. Here, SMAD6 is linked to coronary artery disorder.